Trial Profile
Efficacy and Safety of Morning Intake of Simvast Controlled Release (CR) Tablet Versus Evening Intake of Zocor Tablet in Chronic Kidney Disease Stage(CKD)3, 4 and 5 Patients With Hyperlipidemia: A Randomized, Double-blind, Multicenter Phase 4 Trial (HM-SIM4)
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Simvastatin (Primary)
- Indications Hyperlipidaemia; Kidney disorders
- Focus Therapeutic Use
- Sponsors Hanmi Pharmaceutical
- 05 Apr 2012 New trial record